Whitehawk Therapeutics Inc (WHWK)

$2.90 +0.15 (5.45%)
Market Cap 121.12M
Revenue (ttm) 25.98M
Net Income (ttm) -63.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.15%
Debt to Equity Ratio 0.00
Volume 333,369
Avg Vol 175,020
Day's Range N/A - N/A
Shares Out 47.13M
Stochastic %K 93%
Beta 0.47
Analysts Sell
Price Target $4.50

Company Profile

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Industry: Biotechnology
Sector: Healthcare
Phone: 551 321 2234
Address:
2 Headquarters Plaza, East Building 11th Floor, Morristown, United States
JonCollins
JonCollins Jan. 14 at 8:30 PM
$WHWK showing reversal signs on low volume.
0 · Reply
Jarvis7424
Jarvis7424 Jan. 14 at 6:23 PM
$WHWK cmon $3
0 · Reply
kshonstocks
kshonstocks Jan. 13 at 8:52 PM
$WHWK hitting scans good pattern
0 · Reply
jnc1631
jnc1631 Jan. 8 at 8:37 PM
$WHWK OK good. Now we wait another year… Then those results would be crucial for another capital raise and by then money hopefully is easier
0 · Reply
JohnTrack
JohnTrack Jan. 8 at 5:06 PM
$WHWK checking vibes on this one!
0 · Reply
Jarvis7424
Jarvis7424 Jan. 8 at 2:29 PM
$WHWK IND submitted mid December! Looking forward to first data read out
0 · Reply
JohnTrack
JohnTrack Jan. 8 at 1:53 PM
$WHWK IND cleared, good move! https://www.rapidticker.com/news/whwk-whitehawk-therapeutics-advances-to-clinical-a863b0
0 · Reply
War_Admiral
War_Admiral Jan. 5 at 4:36 PM
$WHWK how do we grow as a company? Make and keep your promises... Where is the IND??
0 · Reply
30DeltaSpy
30DeltaSpy Jan. 4 at 4:07 PM
$WHWK bullish
0 · Reply
BrownianMotionB
BrownianMotionB Dec. 26 at 3:50 PM
$WHWK Risk appetite is present but conditioned on validation. Efficiency initiatives must translate into measurable productivity. Demonstrated durability would lengthen investor time horizons. The forward path ultimately depends on disciplined delivery.
0 · Reply
Latest News on WHWK
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Jan 8, 2026, 8:00 AM EST - 6 days ago

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Dec 1, 2025, 8:00 AM EST - 6 weeks ago

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 8:00 AM EST - 7 weeks ago

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:00 AM EST - 2 months ago

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nov 6, 2025, 8:00 AM EST - 2 months ago

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Oct 24, 2025, 12:30 PM EDT - 2 months ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Oct 16, 2025, 8:30 AM EDT - 3 months ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

TEM

Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 6:44 PM EDT - 4 months ago

Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Sep 2, 2025, 8:00 AM EDT - 4 months ago

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jul 22, 2025, 8:00 AM EDT - 6 months ago

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Jun 19, 2025, 8:00 AM EDT - 7 months ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 8 months ago

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

May 21, 2025, 8:00 AM EDT - 8 months ago

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

May 8, 2025, 4:05 PM EDT - 8 months ago

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 26, 2025, 8:00 AM EDT - 10 months ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:52 AM EDT - 10 months ago

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Mar 18, 2025, 4:00 PM EDT - 10 months ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

JonCollins
JonCollins Jan. 14 at 8:30 PM
$WHWK showing reversal signs on low volume.
0 · Reply
Jarvis7424
Jarvis7424 Jan. 14 at 6:23 PM
$WHWK cmon $3
0 · Reply
kshonstocks
kshonstocks Jan. 13 at 8:52 PM
$WHWK hitting scans good pattern
0 · Reply
jnc1631
jnc1631 Jan. 8 at 8:37 PM
$WHWK OK good. Now we wait another year… Then those results would be crucial for another capital raise and by then money hopefully is easier
0 · Reply
JohnTrack
JohnTrack Jan. 8 at 5:06 PM
$WHWK checking vibes on this one!
0 · Reply
Jarvis7424
Jarvis7424 Jan. 8 at 2:29 PM
$WHWK IND submitted mid December! Looking forward to first data read out
0 · Reply
JohnTrack
JohnTrack Jan. 8 at 1:53 PM
$WHWK IND cleared, good move! https://www.rapidticker.com/news/whwk-whitehawk-therapeutics-advances-to-clinical-a863b0
0 · Reply
War_Admiral
War_Admiral Jan. 5 at 4:36 PM
$WHWK how do we grow as a company? Make and keep your promises... Where is the IND??
0 · Reply
30DeltaSpy
30DeltaSpy Jan. 4 at 4:07 PM
$WHWK bullish
0 · Reply
BrownianMotionB
BrownianMotionB Dec. 26 at 3:50 PM
$WHWK Risk appetite is present but conditioned on validation. Efficiency initiatives must translate into measurable productivity. Demonstrated durability would lengthen investor time horizons. The forward path ultimately depends on disciplined delivery.
0 · Reply
KDoc88
KDoc88 Dec. 24 at 3:21 PM
$WHWK
0 · Reply
KDoc88
KDoc88 Dec. 24 at 3:04 PM
$WHWK that volume can keep rolling!!
0 · Reply
KDoc88
KDoc88 Dec. 24 at 2:58 PM
$WHWK on the move!!!
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 4:32 AM
$WHWK Share Price: $2.67 Contract Selected: Apr 17, 2026 $2.5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.70 – $0.86 Potential Upside: 74% ROI Time to Expiration: 114 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 6:18 PM
Jones Trading has adjusted their stance on Whitehawk Therapeutics ( $WHWK ), setting the rating to Buy with a target price of 7.
0 · Reply
Jarvis7424
Jarvis7424 Dec. 19 at 8:27 PM
$WHWK one week left to file the INDs… cmon
0 · Reply
JonCollins
JonCollins Dec. 19 at 6:39 PM
$WHWK swing trade alerted. Back to 1 month high.
0 · Reply
KDoc88
KDoc88 Dec. 19 at 4:05 PM
$WHWK moving let’s GGOOOO
0 · Reply
Jarvis7424
Jarvis7424 Dec. 15 at 9:37 PM
$WHWK waiting for those IND filings
1 · Reply
KDoc88
KDoc88 Dec. 10 at 9:38 AM
$WHWK about to blow!!… 🚀
0 · Reply
KDoc88
KDoc88 Dec. 8 at 2:25 PM
$WHWK Looking odd premarket
0 · Reply
Investor6
Investor6 Dec. 7 at 5:02 PM
Are there any U.S. companies with Negative Enterprise Value and profitable? The list of such undervaluation is short with only 8 members, according to FinViz. The 7 of them are healthcare and financial stocks, for obvious reasons, and only one is an industrial stock, GTEC. Financial: $DOMH $IBKR $BTCS Healthcare: $ORMP $WHWK KROSS MED Vehicle Components: GTEC.
0 · Reply